HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Spillmann, D. Articles by Lindahl, U. Search for Related Content PubMed PubMed Citation Articles by Spillmann, D. Articles by Lindahl, U.

J Biol Chem, Vol. 273, Issue 25, 15487-15493, June 19, 1998

Defining the Interleukin-8-binding Domain of Heparan Sulfate

Dorothe Spillmann, Dan Witt^¶, and Ulf Lindahl

From the  Department of Medical Biochemistry and Microbiology, Uppsala University, Biomedical Center, S-75 123 Uppsala, Sweden and ^¶ Repligen Corporation, Needham, Massachusetts 02194

Interleukin-8, a member of the CXC chemokine family, has been shown to bind to glycosaminoglycans. It has been suggested that heparan sulfate on cell surfaces could provide specific ligand sites on endothelial cells to retain the highly diffusible inflammatory chemokine for presentation to leukocytes. By using selectively modified heparin and heparan sulfate fragments in a nitrocellulose filter trapping system, we have analyzed sequence requirements for interleukin-8 binding to heparin/heparan sulfate. We demonstrate that the affinity of a monomeric interleukin-8 molecule for heparin/heparan sulfate is too weak to allow binding at physiological ionic strength, whereas the dimeric form of the protein mediates binding to two sulfated domains of heparan sulfate. These domains, each an N-sulfated block of ~6 monosaccharide units, are contained within an ~22-24-mer sequence and are separated by a region of 14 monosaccharide residues that may be fully N-acetylated. Binding to interleukin-8 correlates with the occurrence of the di-O-sulfated disaccharide unit -IdceA(2-OSO₃)-GlcNSO₃(6-OSO₃)-. We suggest that the heparan sulfate sequence binds in horseshoe fashion over two antiparallel-oriented helical regions on the dimeric protein.

---

Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

This article has been cited by other articles:

				A M Patterson, A Cartwright, G David, O Fitzgerald, B Bresnihan, B A Ashton, and J Middleton Differential expression of syndecans and glypicans in chronically inflamed synovium Ann Rheum Dis, May 1, 2008; 67(5): 592 - 601. [Abstract] [Full Text] [PDF]

				J. M. Alexander-Brett and D. H. Fremont Dual GPCR and GAG mimicry by the M3 chemokine decoy receptor J. Exp. Med., December 24, 2007; 204(13): 3157 - 3172. [Abstract] [Full Text] [PDF]

				M. Knappe, S. Bodevin, H.-C. Selinka, D. Spillmann, R. E. Streeck, X. S. Chen, U. Lindahl, and M. Sapp Surface-exposed Amino Acid Residues of HPV16 L1 Protein Mediating Interaction with Cell Surface Heparan Sulfate J. Biol. Chem., September 21, 2007; 282(38): 27913 - 27922. [Abstract] [Full Text] [PDF]

				A. Abramsson, S. Kurup, M. Busse, S. Yamada, P. Lindblom, E. Schallmeiner, D. Stenzel, D. Sauvaget, J. Ledin, M. Ringvall, et al. Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular development Genes & Dev., February 1, 2007; 21(3): 316 - 331. [Abstract] [Full Text] [PDF]

				M.-H. Jang, D. M. Herber, X. Jiang, S. Nandi, X.-M. Dai, G. Zeller, E. R. Stanley, and V. R. Kelley Distinct In Vivo Roles of Colony-Stimulating Factor-1 Isoforms in Renal Inflammation J. Immunol., September 15, 2006; 177(6): 4055 - 4063. [Abstract] [Full Text] [PDF]

				D. Spillmann, A. Lookene, and G. Olivecrona Isolation and Characterization of Low Sulfated Heparan Sulfate Sequences with Affinity for Lipoprotein Lipase J. Biol. Chem., August 18, 2006; 281(33): 23405 - 23413. [Abstract] [Full Text] [PDF]

				J. Kreuger, D. Spillmann, J.-p. Li, and U. Lindahl Interactions between heparan sulfate and proteins: the concept of specificity J. Cell Biol., July 31, 2006; 174(3): 323 - 327. [Abstract] [Full Text] [PDF]

				M. Vanwildemeersch, A.-K. Olsson, E. Gottfridsson, L. Claesson-Welsh, U. Lindahl, and D. Spillmann The Anti-angiogenic His/Pro-rich Fragment of Histidine-rich Glycoprotein Binds to Endothelial Cell Heparan Sulfate in a Zn2+-dependent Manner J. Biol. Chem., April 14, 2006; 281(15): 10298 - 10304. [Abstract] [Full Text] [PDF]

				G. B. t. Dam, S. Kurup, E. M. A. van de Westerlo, E. M. M. Versteeg, U. Lindahl, D. Spillmann, and T. H. van Kuppevelt 3-O-Sulfated Oligosaccharide Structures Are Recognized by Anti-heparan Sulfate Antibody HS4C3 J. Biol. Chem., February 24, 2006; 281(8): 4654 - 4662. [Abstract] [Full Text] [PDF]

				A.A. DeCarlo and J.M. Whitelock The Role of Heparan Sulfate and Perlecan in Bone-regenerative Procedures J. Dent. Res., February 1, 2006; 85(2): 122 - 132. [Abstract] [Full Text] [PDF]

				C. J. Robinson, B. Mulloy, J. T. Gallagher, and S. E. Stringer VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase J. Biol. Chem., January 20, 2006; 281(3): 1731 - 1740. [Abstract] [Full Text] [PDF]

				C. W. Frevert and P. L. Sannes Matrix proteoglycans as effector molecules for epithelial cell function Eur. Respir. Rev., December 1, 2005; 14(97): 137 - 144. [Abstract] [Full Text] [PDF]

				N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898. [Abstract] [Full Text] [PDF]

				S. A. Cain, C. Baldock, J. Gallagher, A. Morgan, D. V. Bax, A. S. Weiss, C. A. Shuttleworth, and C. M. Kielty Fibrillin-1 Interactions with Heparin: IMPLICATIONS FOR MICROFIBRIL AND ELASTIC FIBER ASSEMBLY J. Biol. Chem., August 26, 2005; 280(34): 30526 - 30537. [Abstract] [Full Text] [PDF]

				C. Freeman, L. Liu, M. G. Banwell, K. J. Brown, A. Bezos, V. Ferro, and C. R. Parish Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins J. Biol. Chem., March 11, 2005; 280(10): 8842 - 8849. [Abstract] [Full Text] [PDF]

				Z. Johnson, M. H. Kosco-Vilbois, S. Herren, R. Cirillo, V. Muzio, P. Zaratin, M. Carbonatto, M. Mack, A. Smailbegovic, M. Rose, et al. Interference with Heparin Binding and Oligomerization Creates a Novel Anti-Inflammatory Strategy Targeting the Chemokine System J. Immunol., November 1, 2004; 173(9): 5776 - 5785. [Abstract] [Full Text] [PDF]

				J. Ledin, W. Staatz, J.-P. Li, M. Gotte, S. Selleck, L. Kjellen, and D. Spillmann Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production J. Biol. Chem., October 8, 2004; 279(41): 42732 - 42741. [Abstract] [Full Text] [PDF]

				G. B. ten Dam, E. M. A. van de Westerlo, T. F. C. M. Smetsers, M. Willemse, G. N. P. van Muijen, C. L. R. Merry, J. T. Gallagher, Y. S. Kim, and T. H. van Kuppevelt Detection of 2-O-Sulfated Iduronate and N-Acetylglucosamine Units in Heparan Sulfate by an Antibody Selected against Acharan Sulfate (IdoA2S-GlcNAc)n J. Biol. Chem., September 10, 2004; 279(37): 38346 - 38352. [Abstract] [Full Text] [PDF]

				K. J. Murphy, C. L. R. Merry, M. Lyon, J. E. Thompson, I. S. Roberts, and J. T. Gallagher A New Model for the Domain Structure of Heparan Sulfate Based on the Novel Specificity of K5 Lyase J. Biol. Chem., June 25, 2004; 279(26): 27239 - 27245. [Abstract] [Full Text] [PDF]

				L. J. Marshall, L. S. P. Ramdin, T. Brooks, P. C. DPhil, and J. K. Shute Plasminogen Activator Inhibitor-1 Supports IL-8-Mediated Neutrophil Transendothelial Migration by Inhibition of the Constitutive Shedding of Endothelial IL-8/Heparan Sulfate/Syndecan-1 Complexes J. Immunol., August 15, 2003; 171(4): 2057 - 2065. [Abstract] [Full Text] [PDF]

				P. Jemth, E. Smeds, A.-T. Do, H. Habuchi, K. Kimata, U. Lindahl, and M. Kusche-Gullberg Oligosaccharide Library-based Assessment of Heparan Sulfate 6-O-Sulfotransferase Substrate Specificity J. Biol. Chem., June 27, 2003; 278(27): 24371 - 24376. [Abstract] [Full Text] [PDF]

				G. B. ten Dam, T. Hafmans, J. H. Veerkamp, and T. H. van Kuppevelt Differential Expression of Heparan Sulfate Domains in Rat Spleen J. Histochem. Cytochem., June 1, 2003; 51(6): 727 - 739. [Abstract] [Full Text] [PDF]

				C. W. Frevert, M. G. Kinsella, C. Vathanaprida, R. B. Goodman, D. G. Baskin, A. Proudfoot, T. N. C. Wells, T. N. Wight, and T. R. Martin Binding of Interleukin-8 to Heparan Sulfate and Chondroitin Sulfate in Lung Tissue Am. J. Respir. Cell Mol. Biol., April 1, 2003; 28(4): 464 - 472. [Abstract] [Full Text] [PDF]

				S. E. Stringer, M. S. Nelson, and P. Gupta Identification of an MIP-1alpha -binding heparan sulfate oligosaccharide that supports long-term in vitro maintenance of human LTC-ICs Blood, March 15, 2003; 101(6): 2243 - 2245. [Abstract] [Full Text] [PDF]

				A. M. Vogt, A. Barragan, Q. Chen, F. Kironde, D. Spillmann, and M. Wahlgren Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1 Blood, March 15, 2003; 101(6): 2405 - 2411. [Abstract] [Full Text] [PDF]

				J. Middleton, A. M. Patterson, L. Gardner, C. Schmutz, and B. A. Ashton Leukocyte extravasation: chemokine transport and presentation by the endothelium Blood, December 1, 2002; 100(12): 3853 - 3860. [Abstract] [Full Text] [PDF]

				B. Nardelli, L. Zaritskaya, M. Semenuk, Y. H. Cho, D. W. LaFleur, D. Shah, S. Ullrich, G. Girolomoni, C. Albanesi, and P. A. Moore Regulatory Effect of IFN-{kappa}, A Novel Type I IFN, On Cytokine Production by Cells of the Innate Immune System J. Immunol., November 1, 2002; 169(9): 4822 - 4830. [Abstract] [Full Text] [PDF]

				B.-M. Loo and M. Salmivirta Heparin/Heparan Sulfate Domains in Binding and Signaling of Fibroblast Growth Factor 8b J. Biol. Chem., August 30, 2002; 277(36): 32616 - 32623. [Abstract] [Full Text] [PDF]

				S. E. Stringer, M. J. Forster, B. Mulloy, C. R. Bishop, G. J. Graham, and J. T. Gallagher Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1alpha Blood, August 13, 2002; 100(5): 1543 - 1550. [Abstract] [Full Text] [PDF]

				C. Rolny, D. Spillmann, U. Lindahl, and L. Claesson-Welsh Heparin Amplifies Platelet-derived Growth Factor (PDGF)- BB-induced PDGF alpha -Receptor but Not PDGF beta -Receptor Tyrosine Phosphorylation in Heparan Sulfate-deficient Cells. EFFECTS ON SIGNAL TRANSDUCTION AND BIOLOGICAL RESPONSES J. Biol. Chem., May 24, 2002; 277(22): 19315 - 19321. [Abstract] [Full Text] [PDF]

				C. W. Frevert, R. B. Goodman, M. G. Kinsella, O. Kajikawa, K. Ballman, I. Clark-Lewis, A. E. I. Proudfoot, T. N. C. Wells, and T. R. Martin Tissue-Specific Mechanisms Control the Retention of IL-8 in Lungs and Skin J. Immunol., April 1, 2002; 168(7): 3550 - 3556. [Abstract] [Full Text] [PDF]

				H. Lortat-Jacob, A. Grosdidier, and A. Imberty Structural diversity of heparan sulfate binding domains in chemokines PNAS, February 5, 2002; 99(3): 1229 - 1234. [Abstract] [Full Text] [PDF]

				L. K. Hallak, D. Spillmann, P. L. Collins, and M. E. Peeples Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection J. Virol., November 15, 2000; 74(22): 10508 - 10513. [Abstract] [Full Text]

				Y. Suda, M. Nakamura, S. Koshida, S. Kusumoto, and M. Sobel Novel Photo Affinity Cross-Linking Resin for the Isolation of Heparin Binding Proteins Journal of Bioactive and Compatible Polymers, November 1, 2000; 15(6): 468 - 477. [Abstract] [PDF]

				S. Salek-Ardakani, J. R. Arrand, D. Shaw, and M. Mackett Heparin and heparan sulfate bind interleukin-10 and modulate its activity Blood, September 1, 2000; 96(5): 1879 - 1888. [Abstract] [Full Text] [PDF]

				E. A. Sweeney, G. V. Priestley, B. Nakamoto, R. G. Collins, A. L. Beaudet, and T. Papayannopoulou Mobilization of stem/progenitor cells by sulfated polysaccharides does not require selectin presence PNAS, June 6, 2000; 97(12): 6544 - 6549. [Abstract] [Full Text] [PDF]

				A. Barragan, V. Fernandez, Q. Chen, A. von Euler, M. Wahlgren, and D. Spillmann The Duffy-binding-like domain 1 of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) is a heparan sulfate ligand that requires 12 mers for binding Blood, June 1, 2000; 95(11): 3594 - 3599. [Abstract] [Full Text] [PDF]

				S. Tumova, A. Woods, and J. R. Couchman Heparan Sulfate Chains from Glypican and Syndecans Bind the Hep II Domain of Fibronectin Similarly Despite Minor Structural Differences J. Biol. Chem., March 24, 2000; 275(13): 9410 - 9417. [Abstract] [Full Text] [PDF]

				J. Rong, K. Nordling, I. Bjork, and U. Lindahl A novel strategy to generatebiologically active neo-glycosaminoglycan conjugates Glycobiology, December 1, 1999; 9(12): 1331 - 1336. [Abstract] [Full Text] [PDF]

				T. E. SCHOLZEN, T. BRZOSKA, D.-H. KALDEN, M. HARTMEYER, M. FASTRICH, T. A. LUGER, C. A. ARMSTRONG, and J. C. ANSEL Expression of Functional Melanocortin Receptors and Proopiomelanocortin Peptides by Human Dermal Microvascular Endothelial Cells Ann. N.Y. Acad. Sci., October 20, 1999; 885(1): 239 - 253. [Abstract] [Full Text] [PDF]

				M. Rusnati, G. Tulipano, D. Spillmann, E. Tanghetti, P. Oreste, G. Zoppetti, M. Giacca, and M. Presta Multiple Interactions of HIV-I Tat Protein with Size-defined Heparin Oligosaccharides J. Biol. Chem., October 1, 1999; 274(40): 28198 - 28205. [Abstract] [Full Text] [PDF]

				F. Petersen, E. Brandt, U. Lindahl, and D. Spillmann Characterization of a Neutrophil Cell Surface Glycosaminoglycan That Mediates Binding of Platelet Factor 4 J. Biol. Chem., April 30, 1999; 274(18): 12376 - 12382. [Abstract] [Full Text] [PDF]

				E. A. Wolff, B. Greenfield, D. D. Taub, W. J. Murphy, K. L. Bennett, and A. Aruffo Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44. DEMONSTRATION OF THE INTERACTION BETWEEN RANTES AND CHONDROITIN SULFATE J. Biol. Chem., January 22, 1999; 274(4): 2518 - 2524. [Abstract] [Full Text] [PDF]

				H. Kawashima, M. Hirose, J. Hirose, D. Nagakubo, A. H. K. Plaas, and M. Miyasaka Binding of a Large Chondroitin Sulfate/Dermatan Sulfate Proteoglycan, Versican, to L-selectin, P-selectin, and CD44 J. Biol. Chem., November 3, 2000; 275(45): 35448 - 35456. [Abstract] [Full Text] [PDF]

				M. Tyagi, M. Rusnati, M. Presta, and M. Giacca Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans J. Biol. Chem., January 26, 2001; 276(5): 3254 - 3261. [Abstract] [Full Text] [PDF]

				E. Bengtsson, A. Aspberg, D. Heinegard, Y. Sommarin, and D. Spillmann The Amino-terminal Part of PRELP Binds to Heparin and Heparan Sulfate J. Biol. Chem., December 22, 2000; 275(52): 40695 - 40702. [Abstract] [Full Text] [PDF]

				R. Sadir, F. Baleux, A. Grosdidier, A. Imberty, and H. Lortat-Jacob Characterization of the Stromal Cell-derived Factor-1alpha -Heparin Complex J. Biol. Chem., March 9, 2001; 276(11): 8288 - 8296. [Abstract] [Full Text] [PDF]

				B.-M. Loo, J. Kreuger, M. Jalkanen, U. Lindahl, and M. Salmivirta Binding of Heparin/Heparan Sulfate to Fibroblast Growth Factor Receptor 4 J. Biol. Chem., May 11, 2001; 276(20): 16868 - 16876. [Abstract] [Full Text] [PDF]